HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The indications for second-look laparotomy in ovarian cancer patients].

Abstract
Data on 304 patients with ovarian malignancies (mostly epithelial-72.0%) who had undergone second-look surgery were analysed to develop indications and assess the clinical value of the procedure. Second-look operations were performed 10-22 months after primary surgery in the following clinical settings: (1) clinical remission if wash-offs from the Douglas' pouch peritoneum revealed tumor cells or a high blood-CA-125 level was established (8 patients with stage I-II cancer), (2) remission after 6-10 courses of combination chemotherapy (13 patients with stage III-IV tumor), (3) remission following non-radical primary surgery (117 cases), (4) patients with suspected relapse (144), and (5) cases who were not suspicious for relapse but required laparotomy for concomitant surgical pathology such as, for instance, ventral hernia (22). Intra- and postoperative complications were encountered in 29 out of 304 (9.5%) patients and operative lethality rate was 0.9%. It was shown that improvement in noninvasive methods of monitoring allows to limit indications for second-look surgery in stage III cancer.
AuthorsE I Gulo, V L Vinokurov, Ia V Bokhman
JournalVoprosy onkologii (Vopr Onkol) Vol. 38 Issue 5 Pg. 616-23 ( 1992) ISSN: 0507-3758 [Print] Russia (Federation)
Vernacular TitlePokazaniia k second-look laparotomii u bol'nykh rakom iaichnikov.
PMID1300762 (Publication Type: Comparative Study, English Abstract, Journal Article)
Topics
  • Adenocarcinoma (diagnosis, mortality, pathology, surgery)
  • Adult
  • Cystadenocarcinoma (diagnosis, mortality, pathology, surgery)
  • Endometriosis (diagnosis, mortality, pathology, surgery)
  • Female
  • Humans
  • Laparotomy
  • Middle Aged
  • Neoplasm Staging
  • Ovarian Neoplasms (diagnosis, mortality, pathology, surgery)
  • Prognosis
  • Reoperation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: